Despite improved survival in patients with B cell malignancies who are treated with PI3K inhibitors, researchers found incidences of pneumonitis, infections, and sepsis are higher in these patients.
Data from the CIBMTR demonstrate a need to develop return-to-work interventions for patients who have undergone HCT as treatment of malignant, as well as nonmalignant, conditions.
Results of LAST, the largest study on TKI discontinuation, support using patient-reported outcomes when monitoring remission and symptoms in patients who discontinue TKI therapy.
New scoring method provides a more nuanced risk stratification of VTE than the Khorana score in ambulatory patients with cancer.
Researchers explored the effect of using antibiotics commonly used to treat neutropenic fever on likelihood of aGVHD developing in younger patients who underwent HCT for acute leukemia.
A prospective study followed more than 3000 patients with lymphoma to determine the potential risk for developing anthracycline-induced CVD.
Researchers sought to determine if presence of comorbidities influences the underrepresentation of African American patients with acute myeloid leukemia in clinical trials.
This retrospective analysis compared auto-HSCT and allo-HSCT with tandem auto-HSCT and auto-allo-HSCT to determine which strategy provided better PFS and OS for patients with multiple myeloma.
Researchers sought to determine if corticosteroids can be used to effectively manage CRS in patients undergoing CAR-T therapy without negatively influencing outcomes.
In a safety expansion of the ZUMA-1 study, researchers found that steroids may reduce incidence of CRS and neurologic events associated with CAR-T therapy in patients with relapsed/refractory large B cell lymphoma.
